Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Bacteriophages have "cascading effects" on microbiome

June 12, 2019

Principia Biopharma patents proteasome subunit beta type-8 and/or beta type-9 inhibitors

June 7, 2019

Senju Pharmaceutical synthesizes new PAC1 and/or VPAC1 and/or VPAC2 receptor ligands

June 6, 2019

CCR5 mutation leads to increased mortality

June 4, 2019

FOX-115 improves endurance of motor performances in aged mice

May 20, 2019

Vasopressin V2 receptor antagonists disclosed by Toa Eiyo

May 17, 2019

Boehringer Ingelheim identifies new Bruton tyrosine kinase inhibitors

May 3, 2019

Bristol-Myers Squibb synthesizes new galectin 3 inhibitors

April 30, 2019

Nihon Pharmaceutical and Niigata University present liver integrated bone marrow-derived stem cells

April 18, 2019

Galapagos initiates first-in-human trial of GLPG-3121

April 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...